Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pozanicline in children with ADHD
NCT00528697Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pozanicline in attention deficit hyperactivity disorder (ADHD), sponsored by AbbVie Inc.. Started Sep 2007; status: completed.
02
Drugs
pozanicline
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00528697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528697.